Ignite Creation Date:
2025-12-25 @ 12:20 AM
Ignite Modification Date:
2026-03-07 @ 1:22 AM
Study NCT ID:
NCT02949258
Status:
UNKNOWN
Last Update Posted:
2016-10-31
First Post:
2016-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer
Sponsor:
Jinling Hospital, China
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
B4-2016-LGL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None